Mahyar Etminan, University of British Columbia

Research

Drug Safety Epidemiology Patient Safety Case-Control Study Inflammatory Bowel Disease Large Administrative Databases Multiple Sclerosis Rheumatic Diseases

Latest papers

Association of ciltacabtagene autoleucel with immune effector cell-associated enterocolitis: insights from a large national database.
Blood cancer journal · 2026
Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy.
Cornea · 2026
Realistic presentation of estimated propensity score in the causal directed acyclic graph-response to Kim.
International journal of epidemiology · 2026 · senior author

All 150 publications

Latest funding

Hormonal Contraceptives and Risk of Pseudotumor Cerebri Syndrome in Women of Child Bearing Age
CIHR · 2019 · Nominated PI
$153,000
The risk of multiple sclerosis among users of tumor necrosis factor inhibitors: A Canadian population-based study
CIHR · 2019 · Supervisor
$105,000
Tumor necrosis factor inhibitors (TNFi) and Risk of Multiple Sclerosis
CIHR · 2019 · Nominated PI
$187,424

All 8 grants and awards

150 publications.

01

Association of ciltacabtagene autoleucel with immune effector cell-associated enterocolitis: insights from a large national database.

Frey C, Etminan M, Cherniawsky H

Blood cancer journal2026

DOI: 10.1038/s41408-026-01503-0 PMID: 41963287

02

Ocular Surface Disease as an Immune-related Adverse Event of Immune Checkpoint Inhibitor Therapy.

Frey C, Etminan M, Yeung SN

Cornea2026

DOI: 10.1097/ico.0000000000004299 PMID: 42746766

03

Realistic presentation of estimated propensity score in the causal directed acyclic graph-response to Kim.

Mansournia MA, Nazemipour M, Etminan M

International journal of epidemiology2026Senior author

DOI: 10.1093/ije/dyag013 PMID: 41709675

04

Glucagon-Like Peptide-1 Receptor Agonists and Cancer.

Etminan M, Frey C, Mansournia MA

JAMA oncology2026First author

DOI: 10.1001/jamaoncol.2025.5364 PMID: 41411009

05

Validation of an AI-Assisted Framework for Systematic Bias Assessment in Observational Studies.

Etminan M, Rezaeianzadeh R, Douros A

Journal of evaluation in clinical practice2026First author

DOI: 10.1111/jep.70593 PMID: 42720525

06

Association of Glucagon-Like Peptide-1 Receptor Agonists With Menstrual Events in Reproductive-Aged Patients.

Frey C, Etminan M

Obstetrics and gynecology2026Senior author

DOI: 10.1097/aog.0000000000006367 PMID: 42424619

07

Balancing scores and causal diagrams.

Mansournia MA, Nazemipour M, Etminan M

International journal of epidemiology2025Senior author

DOI: 10.1093/ije/dyaf114 PMID: 40623152

08

Clozapine is associated with an increased risk of Hodgkin and non-Hodgkin lymphoma.

Frey C, Etminan M

Leukemia & lymphoma2025Senior author

DOI: 10.1080/10428194.2025.2461663 PMID: 39937100

09

Acute angle-closure glaucoma risk: a comparative study of escitalopram and antidepressants.

Khan HM, Schendel S, Mikelberg FS, Etminan M

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie2025Senior author

DOI: 10.1016/j.jcjo.2025.01.004 PMID: 39870359

10

Risk of glaucoma with bisphosphonate use in patients with osteoporosis: a case-control study.

He B, Etminan M, Darwich R, Eadie B

Eye (London, England)2025

DOI: 10.1038/s41433-024-03574-4 PMID: 39730976

Hormonal Contraceptives and Risk of Pseudotumor Cerebri Syndrome in Women of Child Bearing Age

Nominated PICIHR2019Project Grant

Principal investigators: Etminan, Mahyar

Keywords: Drug Safety; Epidemiology; Hormonal Contraceptives; Intracranial Hypertension; Large Population Databases; Patient Safety; Pseudotumor Cerebri Syndrome; Women'S Health

$153,000

The risk of multiple sclerosis among users of tumor necrosis factor inhibitors: A Canadian population-based study

SupervisorCIHR2019Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: li, lingyi

Keywords: Case-Control Study; Drug Safety; Health Research; Inflammatory Bowel Diseases; Multiple Sclerosis; Pharmaco-Epidemiology; Population-Based Study; Rheumatic Diseases; Risk; Tumor Necrosis Factor (Tnf) Inhibitors

$105,000

Tumor necrosis factor inhibitors (TNFi) and Risk of Multiple Sclerosis

Nominated PICIHR2019Project Grant

Principal investigators: Etminan, Mahyar; Avina-Zubieta, Juan A; Tremlett, Helen L

Keywords: Case-Control Study; Drug Safety; Epidemiology; Inflammatory Bowel Disease; Large Administrative Databases; Multiple Sclerosis; Patient Safety; Rheumatic Diseases; Tumor Necrosis Factor Inhibitors

$187,424

Severe Cutaneous Adverse Drug Reactions (SCAR) 2019 International Meeting: From Science to Translation

Co-investigatorCIHR2018Planning and Dissemination Grant - Institute Community Support

Principal investigators: Carleton, Bruce C

Keywords: Genetics; Immunology; Patient Care; Pharmacogenomics Testing; Precision Medicine; Predictive Biomarkers; Scientific Meeting; Serious Cutaneous Adverse Drug Reactions; Steven Johnson Syndrome; Toxic Epidermal Necrolysis

$20,000

Risk of Retinal Toxicity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis on Long-term Hydroxychloroquine Therapy

Co-investigatorCIHR2018Project Grant

Principal investigators: Avina-Zubieta, Juan A; Esdaile, John M

Keywords: Ophthalmology; Rheumatology

$707,625

DSEN active Surveillance and Evaluation of Adverse Reactions in Canadian Healthcare (DSEN SEARCH)

Co-investigatorCIHR2014Team Grant: DSEN Collab. Centre for Prospective Studies - Active Surveillance

Principal investigators: Carleton, Bruce C

Keywords: Active Surveillance; Adverse Drug Reactions; Drug Safety; Post-Market Safety Evaluation

$750,000

Planning the Examiniation of Serious Drug Adverse Events with Prescription Drugs used by Older Men

Nominated PICIHR2012Planning Grants - PA: Health Services and Systems for an Aging Population

Principal investigators: Etminan, Mahyar

Keywords: 5-Alpha Reductase Inhibitors; Alpha Blockers; Case-Control Studies; Drug Adverse Events In Older Adults; Large Health Care Databases; Older Men; Pharmacoepidemiology; Prescription Drugs Used By Older Men; Self Controlled-Case Series

$22,250

Prescription medications and the risk of motor vehicle crashes.

Co-investigatorCIHR2012Operating Grant

Principal investigators: Brubacher, Jeffrey R

Keywords: Motor Vehicle Crashes; Prescription Medications

$526,268

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Laurent Azoulay and Laurent Azoulay: 193 shared papers
Laurent Azoulay and Antonios Douros: 17 shared papers
Antonios Douros and Laurent Azoulay: 16 shared papers
Mahyar Etminan and Bruce Carleton: 13 shared papers
Mohsen Sadatsafavi and Larry Lynd: 12 shared papers
Mahyar Etminan and Mohsen Sadatsafavi: 7 shared papers
Mohsen Sadatsafavi and Tetyana Kendzerska: 7 shared papers
Helen Tremlett and Bruce Carleton: 4 shared papers
Mohsen Sadatsafavi and Mark Harrison: 4 shared papers
Helen Tremlett and Mahyar Etminan: 3 shared papers
Mohsen Sadatsafavi and Diane Lacaille: 3 shared papers
Mohsen Sadatsafavi and Kate Johnson: 3 shared papers
Larry Lynd and Mark Harrison: 3 shared papers
Laurent Azoulay and Mahyar Etminan: 2 shared papers
Joanne Matsubara and Mahyar Etminan: 2 shared papers
Mahyar Etminan and Laurent Azoulay: 2 shared papers
Diane Lacaille and Shelby Marozoff: 2 shared papers
Gordon Guyatt and Laurent Azoulay: 1 shared paper
Gordon Guyatt and Helen Tremlett: 1 shared paper
Gordon Guyatt and Fawziah Lalji: 1 shared paper
Gordon Guyatt and Mahyar Etminan: 1 shared paper
Gordon Guyatt and Larry Lynd: 1 shared paper
Gordon Guyatt and Mark Harrison: 1 shared paper
Gordon Guyatt and Rosemin Kassam: 1 shared paper
Gordon Guyatt and Tetyana Kendzerska: 1 shared paper
Laurent Azoulay and Fawziah Lalji: 1 shared paper
Laurent Azoulay and Rosemin Kassam: 1 shared paper
Laurent Azoulay and Tetyana Kendzerska: 1 shared paper
Helen Tremlett and Fawziah Lalji: 1 shared paper
Helen Tremlett and Rosemin Kassam: 1 shared paper
Martin Dawes and Mahyar Etminan: 1 shared paper
Martin Dawes and John Esdaile: 1 shared paper
Martin Dawes and Diane Lacaille: 1 shared paper
Martin Dawes and Eduardo Navajas: 1 shared paper
Martin Dawes and Shelby Marozoff: 1 shared paper
Fawziah Lalji and Mahyar Etminan: 1 shared paper
Mahyar Etminan and John Esdaile: 1 shared paper
Mahyar Etminan and Larry Lynd: 1 shared paper
Mahyar Etminan and Mark Harrison: 1 shared paper
Mahyar Etminan and Diane Lacaille: 1 shared paper
Mahyar Etminan and Jane Buxton: 1 shared paper
Mahyar Etminan and Ryan Flannigan: 1 shared paper
Mahyar Etminan and Matthew Wiens: 1 shared paper
Mahyar Etminan and Antonios Douros: 1 shared paper
Mahyar Etminan and Rosemin Kassam: 1 shared paper
Mahyar Etminan and Tetyana Kendzerska: 1 shared paper
Mahyar Etminan and Bruce Carleton: 1 shared paper
Mahyar Etminan and Kate Johnson: 1 shared paper
Mahyar Etminan and Eduardo Navajas: 1 shared paper
Mahyar Etminan and Lindsay Richter: 1 shared paper
Mahyar Etminan and Shelby Marozoff: 1 shared paper
John Esdaile and Mark Harrison: 1 shared paper
John Esdaile and Eduardo Navajas: 1 shared paper
Bruce Carleton and Bruce Carleton: 1 shared paper

Ophthalmology
Medicine/Respirology
Pediatrics
Medicine/Neurology
Oncology
Dermatology and Skin Science
Health Research Methods, Evidence, and Impact
Other

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2019

Subject: Prospective PhD student: Drug Safety Dear Professor Etminan, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Association of ciltacabtagene autoleucel with immune effector cell-associated enterocolitis: insights from a large national database." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Hormonal Contraceptives and Risk of Pseudotumor Cerebri Syndrome in Women of Child Bearing Age" (2019), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]